The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López Serrano, Alejandro Padín […]
CEFI is organising a seminar on observational studies of medicinal products and patient support programmes, which is set to take place on 15 October. As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. […]
Available for download. The promotion of medicines for human use that have already receive marketing authorization, before the resolution on pricing and the inclusión in the Nacional Health System. Angel García Vidal and Irene Fernández Puyol Health Data 29 Playbook as a gvernance framework fot he sharing and researchwith healthcaredata. Ricard Martínez Martínez, Gabriel López […]
Considerations on the pricing system for medicinal products. Lourdes Fraguas Gadea Abuse of dominant position consisting on predatory prices. Spanish Competition Authority Astrazeneca inhalers Decision. Alfonso Gutiérrez Hernández and Alberto Pérez Hernández Public supply of medicines. Doctrine generated by the Spanish Review Commissions on Public Procurement as of the entry into force of the Spanish […]
There is an ongoing debate about certain national and international policy initiatives concerning the mandatory licensing of COVID-19 vaccine patents and we see the need to clarify certain concepts. In the event of mandatory licensing, it is more than likely that the necessary manufacturing capacity, production conditions and health guarantees would not be met. Indeed, […]
Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo 2021 versión of Pharmaceutical Industry Code of Best Practices. Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria Porxas Roig Regulatory framework aplicable to observational studies with medicines for human use foreseen […]
Recent investigations of the pharmaceutical sector by the competition authorities demonstrate a focus on examining a number of actions that could entail an interruption of supply or even the withdrawal of medicinal products from the market by pharmaceutical companies. Specifically, in the field of pharmaceutical law, the competition authorities have devoted particular attention to two […]
On 19 January CEFI organised a seminar to deepen our understanding of vaccines in times of pandemic. Interest in the debate, reflected in the number of registrations (298) and the quality of the speakers, most of whom are at the forefront of work to provide a vaccine for the current health crisis, ensured the session […]
Fascinating debate on vaccines with 266 registered participants and fantastic presentations by the speakers.
On 19 January 2021, CEFI will hold the online conference entitled Deepening our understanding of vaccines in times of pandemic. Registration is free of charge. Programme and registration
Two new issues of the journal published by CEFI are available: Cuadernos de Derecho Farmacéutico issue 75 (October-December 2020). Comunicaciones en Propiedad Industrial y Derecho de la Competencia issue 91 (September-December 2020).
On 19 January 2021, CEFI will hold an online conference entitled Deepening our understanding of vaccines in times of pandemic. Programme and registration
